Loading
Latest filing published 21 Nov 2022 for Aerie Pharmaceuticals INC, €4.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Casey C. Kopczynski appears in our data through filings on Aerie Pharmaceuticals Inc shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 4 February 2022 and the latest from 21 November 2022.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 21 November 2022, reports a transaction of €4.1M in Aerie Pharmaceuticals Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations